Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...

LONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top-selling medicines ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

My monthly update and commentary on the top dividend stock picks sourced from Barron's, March 2025 edition. Standout choices included AT&T (T). Read the full report here on Seeking Alpha.

A vial of Botox, sold by AbbVie, is seen next to its packaging in a photo illustration in Manhattan ... selling medicines made in Europe from Novo Nordisk's Wegovy for weight loss to Merck's ...

After America imposed a 25% tariff on steel and aluminium on March 12th, it said it would charge punitive levies on €8bn ...

The health sector provides a stark illustration of the consequences ... amongst women and those from diverse backgrounds. Novo Nordisk has reached the end of its two-year suspension from the ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Novo Nordisk announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and ...